DoJ Launching “Pharmaceutical Fraud Initiative” Ahead Of Medicare Rx
Executive Summary
The Department of Justice is launching a "pharmaceutical fraud initiative" to coordinate and increase investigative resources ahead of the Medicare drug benefit's implementation, DoJ Criminal Division Fraud Section Deputy Chief Karen Morrissette said